Explore HCV and Drug User Health Center of Excellence Learning Pathways (LP)
Implementing The 72-Hour Rule in Clinical Practice (Online)
Description:
Effective February 19, 2026, New York State law permits clinicians to administer or dispense up to a 72-hour supply of methadone or buprenorphine to manage opioid withdrawal, while arranging referral and linkage to ongoing care for individuals with opioid use disorder, in accordance with federal regulations. This update—informally known as the “72-Hour Rule”—will have implications for clinicians across the state. CME is not provided.
Trainings Included:
- Implementing the 72-Hour Rule in Clinical Practice
- Implementing the 72-Hour Rule in the Emergency Department
- Implementing the 72-Hour Rule in the Inpatient Setting
- Implementing the 72-Hour Rule in the Outpatient Setting
Click here to register
Hepatitis C Care Continuum (Online)
Description:
Trainings Included:
- Hepatitis C Screening and Pre-Treatment Evaluation
- Hepatitis C Treatment
- Achieved SVR, What’s Next? Hepatitis C Post-treatment Outcomes and Management
Click here to register
Satisfy the DEA Education Requirement on Substance Use Disorders (Online)
Description:
In June 2023, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of eight hours of training on the treatment and management of patients with opioid or other substance use disorder for practitioners who are applying for or renewing their DEA license. As an ACCME-accredited organization, CEI recommends the following courses to meet the DEA requirement.
Refer to official communication from the DEA and SAMHSA for more information:
- https://deadiversion.usdoj.gov/pubs/docs/MATE_Training_Letter_Final.pdf
- https://www.samhsa.gov/substance-use/treatment/statutes-regulations-guidelines/mate-act/curricular-elements-training
Trainings Included:
- Best Practices for Buprenorphine Prescribing
- Extended-Release Buprenorphine for Opioid Use Disorder
- Clinical Practice Guidelines for the Treatment of Alcohol Use Disorder - V100
- Tobacco Use Disorder Treatment among People Who Use Drugs
- Clinical Approaches to Medical Cannabis
- NYS ETE - Clinical Strategies for Prescribing and Tapering Benzodiazepines
- What Clinicians Need to Know About Novel Substances in New York State’s Drug Supply
- Caring for Pregnant and Postpartum Persons with Opioid Use Disorder